Avalo Therapeutics (NASDAQ:AVTX – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at BTIG Research in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $58.00 target price on the stock. BTIG Research’s price objective points to a potential upside of 304.75% from the stock’s previous close. […]

Oracle (NYSE:ORCL – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at BTIG Research in a research note issued on Friday,Benzinga reports. They currently have a $400.00 price objective on the enterprise software provider’s stock. BTIG Research’s price objective suggests a potential upside of 69.12% from the stock’s current price. Other […]

Steven Madden (NASDAQ:SHOO – Get Free Report)‘s stock had its “buy” rating reiterated by BTIG Research in a research report issued to clients and investors on Thursday,Benzinga reports. They presently have a $50.00 target price on the textile maker’s stock. BTIG Research’s price target would indicate a potential upside of 14.16% from the stock’s current […]